Modulation by treatment of tumor infiltrating lymphocytes (TILs) and PDL1 expression in triple-negative breast cancer in the ETNA trial.

被引：0
|
作者：
Bianchini, Giampaolo
Smart, Chanel
Mansutti, Mauro
Luck, Hans-Joachim
Zambelli, Stefania
Olier, Clara
Anton, Antonio
Bisagni, Giancarlo
Merlini, Laura
Murillo, Serafin Morales
Martinez, Lourdes Calvo
Chacon, Jose Ignacio
Semiglazov, Vladimir
Thill, Marc
Chan, Arlene
Tusquets, Ignasi
Licata, Luca
Valagussa, Pinuccia
Viale, Giuseppe
Gianni, Luca
机构：
[1] RCCS San Raffaele Hosp, Milan, Italy
[2] Univ Hosp Udine, Udine, Italy
[3] Practice Gynecol Oncol, Hannover, Germany
[4] Hosp Univ Fdn Alcorcon, GEICAM Spanish Breast Canc Grp, Alcorcon, Spain
[5] Hosp Univ Miguel Servet, Geicam Spanish Breast Canc Grp, Zaragoza, Spain
[6] Azienda USL IRCCS, Reggio Emilia, Italy
[7] Osped Civile S Bortolo, Vicenza, Italy
[8] Hosp Arnau Vilanova, Geicam Spanish Breast Canc Grp, Lleida, Spain
[9] Hosp Juan Canalejo, Geicam Spanish Breast Canc Grp, La Coruna, Spain
[10] Hosp Virgen Salud, Toledo, Spain
[11] Geicam Spanish Breast Canc Grp, La Coruna, Spain
[12] Minist Healthcare Russian Federat, Natl Med Res Ctr Oncol, Fed State Budget Inst, St Petersburg, Russia
[13] Agaples Markus Krankenhaus, Frankfurt, Germany
[14] Breast Canc Res Ctr Western Australia, Perth, WA, Australia
[15] Curtin Univ, Perth, WA, Australia
[16] Hosp del Mar Res Inst IMIM, Barcelona, Spain
[17] Fdn Michelangelo, Milan, Italy
[18] IRCCS, European Inst Oncol, Div Pathol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
555
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tumor-infiltrating lymphocytes (TILs) and PDL1 expression in lung cancer brain metastases
    Berghoff, A. S.
    Cansu, I.
    Rajky, O.
    Ricken, G.
    Widhalm, G.
    Dieckmann, K.
    Birner, P.
    Oberndorfer, F.
    Dome, B.
    Bartsch, R.
    Zielinski, C.
    Preusser, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S593 - S593
  • [2] Relationship among PDL1, androgen receptor (AR) and tumour infiltrating lymphocytes (TILs) in early triple negative breast cancer
    Sanchez-Cousido, L. F.
    Honrado Franco, E.
    Sanz Guadarrama, O.
    Lopez Gonzalez, L.
    Garcia-Palomo, A.
    Lopez Flores, M.
    Rojas Piedra, M.
    Tavara Silva, B.
    Delgado Sillero, I.
    Castanon Lopez, C.
    Diz Tain, P.
    Rodriguez Sanchez, A.
    Nieto Mangudo, B.
    Lopez-Gonzalez, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S328 - S329
  • [3] PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy
    Mathur, Sandeep
    Johnson, Anjana
    Deo, S. V. S.
    Gogia, Ajay
    Kahol, Shruti
    Jain, Deepali
    Iyer, Venkateswaran
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 208 - 209
  • [4] PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy
    Mathur, Sandeep
    Johnson, Anjana
    Deo, S. V. S.
    Gogia, Ajay
    Kahol, Shruti
    Jain, Deepali
    Iyer, Venkateswaran
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 208 - 209
  • [5] Prevalence of PDL1 and tumor infiltrating lymphocytes (TILs) in primary and metastatic TNBC
    Li, Yijin
    Chang, Ching-Wei
    Tran, David
    Denker, Mitchell
    Hegde, Priti
    Molinero, Luciana
    CANCER RESEARCH, 2018, 78 (04)
  • [6] PDL1 and PD1 expression by tumor infiltrating lymphocytes in primary breast cancer
    Solinas, C.
    Buisseret, L.
    Garaud, S.
    Boisson, A.
    Naveaux, C.
    de Wind, R.
    Van den Eynden, G.
    Brown, D.
    Larsimont, D.
    Sotiriou, C.
    Willard-Gallo, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 4 - 4
  • [7] Treatment of advanced or metastatic triple-negative breast cancer with adoptive therapy of PD1+tumor-infiltrating lymphocytes (TILS001 trial)
    Chic, Nuria
    Ciruelos, Eva
    Saura, Cristina
    Gonzalez, Europa-Azucena
    Alvarez-Vallina, Luis
    Lasarte, Juan Jose
    Gros, Alena
    Villanueva, Lorea
    Canes, Jordi
    Angelats, Laura
    Prat, Aleix
    Pascual, Tomas
    Santisteban, Marta
    Juan, Manel
    CANCER RESEARCH, 2023, 83 (05)
  • [8] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Leon-Ferre, Roberto A.
    Jonas, Sarah Flora
    Salgado, Roberto
    Loi, Sherene
    de Jong, Vincent
    Carter, Jodi M.
    Nielsen, Torsten O.
    Leung, Samuel
    Riaz, Nazia
    Chia, Stephen
    Jules-Clement, Gerome
    Curigliano, Giuseppe
    Criscitiello, Carmen
    Cockenpot, Vincent
    Lambertini, Matteo
    Suman, Vera J.
    Linderholm, Barbro
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    Timmermans, A. Mieke
    Shimoi, Tatsunori
    Yazaki, Shu
    Yoshida, Masayuki
    Kim, Sung-Bae
    Lee, Hee Jin
    Dieci, Maria Vittoria
    Bataillon, Guillaume
    Vincent-Salomon, Anne
    Andre, Fabrice
    Kok, Marleen
    Linn, Sabine C.
    Goetz, Matthew P.
    Michiels, Stefan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (13): : 1135 - 1144
  • [9] ROLE OF PDL1 EXPRESSION AND TUMOR INFILTRATING LYMPHOCYTES (TILS) IN GLIOBLASTOMA (GBM) AND BRAIN METASTASES (BM)
    Berghoff, A. S.
    Woehrer, A. W.
    Widhalm, G.
    Oberndorfer, F.
    Dieckmann, K.
    Filipits, M.
    Marosi, C.
    Hoeller, C.
    Wick, W.
    Preusser, M.
    ANNALS OF ONCOLOGY, 2014, 25
  • [10] PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer
    Ren, Xinyu
    Wu, Huanwen
    Lu, Junliang
    Zhang, Yuhan
    Luo, Yufeng
    Xu, Qianqian
    Shen, Songjie
    Liang, Zhiyong
    CANCER BIOLOGY & THERAPY, 2018, 19 (05) : 373 - 380
12345